80 related articles for article (PubMed ID: 3536537)
1. Specific immunotherapy in insulin-dependent diabetes mellitus (preliminary report).
Lohmann D; Bierwolf B; Krug J; Lampeter E; Verlohren HJ
Exp Clin Endocrinol; 1986 Aug; 87(3):333-6. PubMed ID: 3536537
[TBL] [Abstract][Full Text] [Related]
2. Effect of lymphocytes and serum from probands before and after manifestation of type 1 (insulin-dependent) diabetes on rat islets in vitro.
Köhler E; Knospe S; Rjasanowski I; Michaelis D
Exp Clin Endocrinol; 1988 Dec; 92(2):182-8. PubMed ID: 3072214
[TBL] [Abstract][Full Text] [Related]
3. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D
Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366
[TBL] [Abstract][Full Text] [Related]
4. A follow-up study of cell-mediated cytotoxicity and beta cell function in type I diabetes.
Bierwolf B; Verlohren HJ; Lohmann D; Lampeter EF; Krug J
Exp Clin Endocrinol; 1987 Aug; 89(3):363-7. PubMed ID: 3311778
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune reactions against rat pancreatic islets mediated by antibodies from type I diabetic patients.
Kruschel B; Jahr H; Marx S; Michaelis D
Biomed Biochim Acta; 1984; 43(5):635-9. PubMed ID: 6383367
[TBL] [Abstract][Full Text] [Related]
6. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for insulin-dependent diabetics?
Rossini AA
N Engl J Med; 1983 Feb; 308(6):333-5. PubMed ID: 6337326
[No Abstract] [Full Text] [Related]
8. Autoimmune disorders in diabetes.
Boitard C; Debray-Sachs M; Bach JF
Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
[TBL] [Abstract][Full Text] [Related]
9. Defect of cellular suppressor function in the pathogenesis of type I diabetes mellitus.
Lohmann D; Lampeter E; Krug J; Bierwolf B; Verlohren HJ
Exp Clin Endocrinol; 1987 Aug; 89(3):340-4. PubMed ID: 2959493
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
[TBL] [Abstract][Full Text] [Related]
11. [Immuno- and regeneration therapy of recently diagnosed diabetes mellitus type I].
Huth E
Klin Padiatr; 1985; 197(2):75-84. PubMed ID: 3157826
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immune reactions against islets of Langerhans in diabetes-prone BB rats.
Knospe S; Köhler E; Klöting I
Exp Clin Endocrinol; 1987 Aug; 89(3):290-6. PubMed ID: 3311775
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activity of sera from diabetic BB rats against BB rat islet--a functional study.
Ziegler B; Klöting I; Besch W; Ziegler M; Hahn HJ
Diabetes Res; 1987 Feb; 4(2):67-72. PubMed ID: 3555954
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects of islet cell surface antibodies.
Hehmke B; Kohnert KD; Dietz H; Zühlke H
Acta Biol Med Ger; 1982; 41(12):1117-22. PubMed ID: 6765153
[TBL] [Abstract][Full Text] [Related]
15. Early intervention in insulin-dependent diabetes mellitus.
Cahill GF
Curr Probl Clin Biochem; 1983; 12():108-18. PubMed ID: 6418442
[No Abstract] [Full Text] [Related]
16. Complement-mediated cytotoxic effects of islet cell surface antibodies: factors influencing the sensitivity of the target cells.
Jahr H; Kruschel B; Walter BM; Kohnert KD
Biomed Biochim Acta; 1984; 43(5):641-6. PubMed ID: 6383368
[TBL] [Abstract][Full Text] [Related]
17. Effects of incubation of islet cells with transforming growth factor beta (TGF-beta) on their susceptibility to diabetic lymphocyte mediated destruction in the rat, in vitro.
Koevary SB
Diabetes Res; 1991 Nov; 18(3):123-7. PubMed ID: 1841822
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of insulin-dependent (type I) diabetes mellitus].
Weber B
Monatsschr Kinderheilkd; 1985 Jun; 133(6):355-63. PubMed ID: 2931586
[No Abstract] [Full Text] [Related]
19. Lymphocyte transfusion in recent onset type I diabetes mellitus--a one-year follow-up of cell-mediated anti-islet cytotoxicity and C-peptide secretion.
Krug J; Verlohren HJ; Bierwolf B; Lampeter E; Borte M; Nietzschmann U; Haustein B; Lohmann D
J Autoimmun; 1990 Oct; 3(5):601-9. PubMed ID: 2252528
[TBL] [Abstract][Full Text] [Related]
20. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
Sobel DO; Creswell K
Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
